• Entertainment
  • Finance
  • Marketing
  • Real Estate
  • Technology
  • Social
National Journal Community Of e-Experts
Finance 0

Goldman Sachs: These 5 Stocks Are Perfect For Trade War Volatility

By Kurt Osterberg · On April 8, 2018

As global trade tensions play havoc with the financial markets, one strategy is to consider stocks with relatively large domestic sales exposure. This is the tactic recommended by Goldman Sachs.

“Below the surface of the market, trade conflict would benefit the performance of the most domestic-facing U.S. stocks relative to the most foreign-facing firms,” the firm says. Most encouragingly, the firm’s chief US economist- Jan Hatzius- is still bullish on the general economy despite China’s recent retaliation. He told CNBC: “We think that means there is more risk there, but not enough for us to change our baseline forecast for an economy that is growing above trend and a Federal Reserve that continues to hike once a quarter.”

So with this in mind, we extracted five intriguing stock ideas from Goldman Sachs’ domestic sales basket list. As you will see, all of these stocks have little to no international exposure.

At the same time, we delve into the outlook on these stocks from TipRanks’ top analysts. We rank analysts based on their success rate and average return so that you can follow the advice of analysts who consistently crush the market.

Let’s take a closer look now:

CVS Health

100% US Sales

Drugstore giant CVS Health (NYSE:CVS) has 100% support from top analysts right now. In the last three months, the stock has received three back-to-back buy ratings from the Street’s best-performing analysts. And luckily for investors, on average these analysts are predicting 48% upside potential from the current share price.

CVS Health is currently fighting hard to push through a massive $69 billion deal with one of the US’s biggest health insurers: Aetna (NYSE:AET). Oppenheimer’s Mohan Naidu has his fingers crossed that the deal will go through and says: “Increasing confidence on the successful Aetna transaction makes us excited.” He believes the deal would “strengthen CVS’s position and have significant positive long-term impact.”

Print Friendly, PDF & Email

Share Tweet

Kurt Osterberg

You Might Also Like

  • Finance

    Bored Ape Metaverse Launch Date set for April 30

  • Finance

    Celebrity Backed NFT Collections to Invest in 2022

  • Finance

    Bored Ape Metaverse Launch Date set for April 30

No Comments

Leave a reply Cancel reply

Top Finance

  • 3 Best Large-Cap Blend Mutual Funds For Enticing Returns 3 Best Large-Cap Blend Mutual Funds For Enticing Returns
  • Hedge Funds In The US Hedge Funds In The US
  • What is Value Chain Analysis? How to Deliver Value & Gain a Competitive Advantage What is Value Chain Analysis? How to Deliver Value & Gain a Competitive Advantage
  • 5 Ridiculously Useful Non-Monetary Reward Examples that Improve Employee Engagement 5 Ridiculously Useful Non-Monetary Reward Examples that Improve Employee Engagement
  • Chart: Amazon’s Dominance In Ecommerce Chart: Amazon’s Dominance In Ecommerce

New Posts

  • Bored Ape Metaverse Launch Date set for April 30

    Bored Ape Metaverse Launch Date set for April 30

    April 24, 2022
  • Celebrity Backed NFT Collections to Invest in 2022

    Celebrity Backed NFT Collections to Invest in 2022

    April 24, 2022
  • Bored Ape Metaverse Launch Date set for April 30

    Bored Ape Metaverse Launch Date set for April 30

    April 24, 2022
  • Mutant Ape Yacht Club Hits 32 ETH All Time High Price Floor

    Mutant Ape Yacht Club Hits 32 ETH All Time High Price Floor

    April 22, 2022
  • Rare CryptoPunk #7756 sells for $3.2 million (1050 ETH)

    Rare CryptoPunk #7756 sells for $3.2 million (1050 ETH)

    April 22, 2022
  • About
  • Contact Us
  • Privacy & Policy
  • Sitemap
  • Terms of use

Copyright © 2018-2021 NJCEE. All Rights Reserved.